Literature DB >> 32095189

The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab.

Lan Wang1, Miriam Bargout1, Jane Date Hon2, Bassam Yaghmour3, Ann Mohrbacher1, George Yaghmour1.   

Abstract

Entities:  

Year:  2020        PMID： 32095189      PMCID： PMC7011905          DOI： 10.14740/wjon1255

Source DB:  PubMed          Journal:  World J Oncol        ISSN： 1920-4531


× No keyword cloud information.
  9 in total

1.  FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome.

Authors:  Yvette L Kasamon; Haiyan Chen; R Angelo de Claro; Lei Nie; Jingjing Ye; Gideon M Blumenthal; Ann T Farrell; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2019-07-31       Impact factor: 12.531

2.  Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient.

Authors:  Yoshimi Ishii; Megumi Itabashi; Ayumi Numata; Wataru Yamamoto; Kenji Motohashi; Maki Hagihara; Kenji Matsumoto; Shin Fujisawa
Journal:  Intern Med       Date:  2016-03-15       Impact factor: 1.271

3.  Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.

Authors:  Xiao Ni; Jeffrey L Jorgensen; Meghali Goswami; Pramoda Challagundla; William K Decker; Youn H Kim; Madeleine A Duvic
Journal:  Clin Cancer Res       Date:  2014-11-05       Impact factor: 12.531

Review 4.  Expression of CCR4 in adult T-cell leukemia.

Authors:  Osamu Yoshie
Journal:  Leuk Lymphoma       Date:  2005-02

5.  Angioimmunoblastic T-Cell Lymphoma.

Authors:  Mariko Yabe; Ahmet Dogan; Steven M Horwitz; Alison J Moskowitz
Journal:  Cancer Treat Res       Date:  2019

6.  Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution.

Authors:  Kazuharu Kamachi; Takero Shindo; Masaharu Miyahara; Kazutaka Kitaura; Michiaki Akashi; Tadasu Shin-I; Ryuji Suzuki; Koichi Oshima; Shinya Kimura
Journal:  Int J Hematol       Date:  2018-10-27       Impact factor: 2.319

7.  Development of Epstein-Barr Virus-related Primary Diffuse Large B-cell Lymphoma of the Central Nervous System in a Patient with Peripheral T-cell Lymphoma, Not Otherwise Specified after Mogamulizumab Treatment.

Authors:  Hiroaki Tanaka; Hanako Aoki; Yasumasa Sugita; Ryo Shimizu; Katsunari Kiko; Hidetoshi Mochida; Yoshio Suzuki
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

8.  Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.

Authors:  Takashi Ishida; Atae Utsunomiya; Tatsuro Jo; Kazuhito Yamamoto; Koji Kato; Shinichiro Yoshida; Shigeki Takemoto; Hitoshi Suzushima; Yukio Kobayashi; Yoshitaka Imaizumi; Kenichi Yoshimura; Kouichi Kawamura; Takeshi Takahashi; Kensei Tobinai; Ryuzo Ueda
Journal:  Cancer Sci       Date:  2017-08-28       Impact factor: 6.716

9.  Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.

Authors:  Masao Nakagawa; Roland Schmitz; Wenming Xiao; Carolyn K Goldman; Weihong Xu; Yandan Yang; Xin Yu; Thomas A Waldmann; Louis M Staudt
Journal:  J Exp Med       Date:  2014-12-08       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.